Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 277

1.

Standardisation of myositis-specific antibodies: where are we today?

Mahler M, Vulsteke JB, Bossuyt X, De Langhe E, Satoh M.

Ann Rheum Dis. 2019 Aug 3. pii: annrheumdis-2019-216003. doi: 10.1136/annrheumdis-2019-216003. [Epub ahead of print] No abstract available.

PMID:
31377729
2.

Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines.

Hernandez N, Bucciol G, Moens L, Le Pen J, Shahrooei M, Goudouris E, Shirkani A, Changi-Ashtiani M, Rokni-Zadeh H, Sayar EH, Reisli I, Lefevre-Utile A, Zijlmans D, Jurado A, Pholien R, Drutman S, Belkaya S, Cobat A, Boudewijns R, Jochmans D, Neyts J, Seeleuthner Y, Lorenzo-Diaz L, Enemchukwu C, Tietjen I, Hoffmann HH, Momenilandi M, Pöyhönen L, Siqueira MM, de Lima SMB, de Souza Matos DC, Homma A, Maia MLS, da Costa Barros TA, de Oliveira PMN, Mesquita EC, Gijsbers R, Zhang SY, Seligman SJ, Abel L, Hertzog P, Marr N, Martins RM, Meyts I, Zhang Q, MacDonald MR, Rice CM, Casanova JL, Jouanguy E, Bossuyt X.

J Exp Med. 2019 Jul 3. pii: jem.20182295. doi: 10.1084/jem.20182295. [Epub ahead of print]

PMID:
31270247
3.

A comparison of a fluorescence enzyme immunoassay versus indirect immunofluorescence for initial screening of connective tissue diseases: Systematic literature review and meta-analysis of diagnostic test accuracy studies.

Orme ME, Andalucia C, Sjölander S, Bossuyt X.

Best Pract Res Clin Rheumatol. 2018 Aug;32(4):521-534. doi: 10.1016/j.berh.2019.03.005. Epub 2019 Apr 15. Review.

4.

Antinuclear antibodies by indirect immunofluorescence and solid phase assays.

Bossuyt X, Claessens J, De Langhe E, Belmondo T, Westhovens R, Hue S, Poesen K, Blockmans D, Mahler M, Fritzler MJ.

Ann Rheum Dis. 2019 May 10. pii: annrheumdis-2019-215443. doi: 10.1136/annrheumdis-2019-215443. [Epub ahead of print] No abstract available.

PMID:
31076390
5.

Anti-OJ autoantibodies: Rare or underdetected?

Vulsteke JB, Satoh M, Malyavantham K, Bossuyt X, De Langhe E, Mahler M.

Autoimmun Rev. 2019 Jul;18(7):658-664. doi: 10.1016/j.autrev.2019.05.002. Epub 2019 May 3. Review.

PMID:
31059843
6.

Harmonizing by reducing inter-run variability: performance evaluation of a quality assurance program for antinuclear antibody detection by indirect immunofluorescence.

Bogaert L, Van den Bremt S, Schouwers S, Bossuyt X, Van Hoovels L.

Clin Chem Lab Med. 2019 Jun 26;57(7):990-998. doi: 10.1515/cclm-2018-0933.

PMID:
30838836
7.

Auto-inflammation in a Patient with a Novel Homozygous OTULIN Mutation.

Nabavi M, Shahrooei M, Rokni-Zadeh H, Vrancken J, Changi-Ashtiani M, Darabi K, Manian M, Seif F, Meyts I, Voet A, Moens L, Bossuyt X.

J Clin Immunol. 2019 Feb;39(2):138-141. doi: 10.1007/s10875-019-00599-3. Epub 2019 Feb 22. No abstract available.

PMID:
30796585
8.

Clinical spectrum of the anti-GQ1b antibody syndrome: a case series of eight patients.

de Bruyn A, Poesen K, Bossuyt X, Heremans IP, Claeys T, Depuydt CE, Van Damme P, Claeys KG.

Acta Neurol Belg. 2019 Mar;119(1):29-36. doi: 10.1007/s13760-019-01093-8. Epub 2019 Feb 12.

PMID:
30747336
9.

Increased prevalence of anti-DFS70 antibodies in young females: experience from a large international multi-center study on blood donors.

Albesa R, Sachs U, Infantino M, Manfredi M, Benucci M, Baus Y, Lutterbeck S, Andrade L, Morris K, Friedenberg A, Casas S, Bossuyt X, Mahler M.

Clin Chem Lab Med. 2019 Jun 26;57(7):999-1005. doi: 10.1515/cclm-2018-1233.

PMID:
30739097
10.

Added Value of Fecal Calprotectin to Support the Diagnosis of Spondyloarthropathies.

VAN Hoovels L, VAN DEN Bremt S, Schiemsky T, Cauchie M, Vander Cruyssen B, Bossuyt X, VAN DER Steen K, Stubbe M.

J Rheumatol. 2019 Feb;46(2):215-216. doi: 10.3899/jrheum.180432. No abstract available.

PMID:
30710003
11.

Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays.

Damoiseaux J, Vulsteke JB, Tseng CW, Platteel ACM, Piette Y, Shovman O, Bonroy C, Hamann D, De Langhe E, Musset L, Chen YH, Shoenfeld Y, Allenbach Y, Bossuyt X.

Autoimmun Rev. 2019 Mar;18(3):293-305. doi: 10.1016/j.autrev.2018.10.004. Epub 2019 Jan 11. Review.

PMID:
30639643
12.

Frequency and Pattern of IgE-mediated Sensitization to Aero and Food Allergens in Ahvaz, Province of Khuzestan in Southwestern Iran.

Shahrooei M, Fayezi A, Shokouhi Shoormasti R, Zakavi F, Golpasand Hagh L, Van Eldere J, Bossuyt X, Van Hoeyveld E.

Iran J Allergy Asthma Immunol. 2018 Aug 12;17(4):393-397. doi: 10.18502/ijaai.v17i4.99.

13.

Investigations in systemic vasculitis. The role of the laboratory.

Csernok E, Bossuyt X.

Best Pract Res Clin Rheumatol. 2018 Feb;32(1):52-62. doi: 10.1016/j.berh.2018.07.005. Epub 2018 Aug 16. Review.

PMID:
30526898
14.

Harmonisation of laboratory tests for rheumatic diseases: still a long way to go.

Van Hoovels L, Bossuyt X.

Ann Rheum Dis. 2018 Dec 4. pii: annrheumdis-2018-214696. doi: 10.1136/annrheumdis-2018-214696. [Epub ahead of print] No abstract available.

PMID:
30514700
15.

Revised 2017 international consensus on ANCA testing in small vessel vasculitis: support from an external quality assessment.

Broeders S, Goletti S, Tomasi JP, Bonroy C, Humbel RL, Lutteri L, Schouwers S, Van Hoovels L, Vercammen M, Bossuyt X.

Ann Rheum Dis. 2018 Sep 5. pii: annrheumdis-2018-214078. doi: 10.1136/annrheumdis-2018-214078. [Epub ahead of print] No abstract available.

PMID:
30185413
16.

Standardization and harmonization of autoimmune diagnostics.

Jacobs JFM, Bossuyt X.

Clin Chem Lab Med. 2018 Sep 25;56(10):1563-1567. doi: 10.1515/cclm-2018-0807. No abstract available.

17.

Prevalence and clinical correlates of rheumatoid factor and anticitrullinated protein antibodies in patients with idiopathic inflammatory myopathy.

Ide V, Bossuyt X, Blockmans D, De Langhe E.

RMD Open. 2018 Jul 25;4(2):e000661. doi: 10.1136/rmdopen-2018-000661. eCollection 2018.

18.

Lessons learned from the study of human inborn errors of innate immunity.

Bucciol G, Moens L, Bosch B, Bossuyt X, Casanova JL, Puel A, Meyts I.

J Allergy Clin Immunol. 2019 Feb;143(2):507-527. doi: 10.1016/j.jaci.2018.07.013. Epub 2018 Aug 1.

PMID:
30075154
19.

Antinuclear antibody as entry criterion for classification of systemic lupus erythematosus: pitfalls and opportunities.

Willems P, De Langhe E, Westhovens R, Vanderschueren S, Blockmans D, Bossuyt X.

Ann Rheum Dis. 2019 Aug;78(8):e76. doi: 10.1136/annrheumdis-2018-213821. Epub 2018 Jun 23. No abstract available.

PMID:
29936439
20.

Analytical performance of the single well titer function of NOVA View®: good enough to omit ANA IIF titer analysis?

Van Hoovels L, Schouwers S, Van den Bremt S, Bogaert L, Vandeputte N, Vercammen M, Bossuyt X.

Clin Chem Lab Med. 2018 Oct 25;56(11):258-261. doi: 10.1515/cclm-2018-0338. No abstract available.

PMID:
29804100
21.

Clinical relevance of ANCA in small-vessel vasculitis: positioning of antigen-specific immunoassays.

Damoiseaux J, Bossuyt X.

Clin Rheumatol. 2018 Jul;37(7):2015-2016. doi: 10.1007/s10067-018-4154-7. Epub 2018 May 25. No abstract available.

PMID:
29799606
22.

Antigen excess detection by automated assays for free light chains.

Bossuyt X, Delforge M, Reynders M, Dillaerts D, Sprangers B, Fostier K, Poesen K, Vercammen M.

Clin Chem Lab Med. 2018 Aug 28;56(9):e235-e238. doi: 10.1515/cclm-2017-0977. No abstract available.

PMID:
29679525
23.

Variation in antinuclear antibody detection by automated indirect immunofluorescence analysis.

Van Hoovels L, Schouwers S, Van den Bremt S, Bossuyt X.

Ann Rheum Dis. 2019 Jun;78(6):e48. doi: 10.1136/annrheumdis-2018-213543. Epub 2018 Apr 20. No abstract available.

PMID:
29678938
24.

Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used.

Bossuyt X, Delforge M, Reynders M, Dillaerts D, Sprangers B, Fostier K, Poesen K, Vercammen M.

Leukemia. 2018 Aug;32(8):1815-1818. doi: 10.1038/s41375-018-0041-0. Epub 2018 Apr 20. No abstract available.

PMID:
29674643
25.

Unending story of the indirect immunofluorescence assay on HEp-2 cells: old problems and new solutions?

Meroni PL, Chan EK, Damoiseaux J, Andrade LEC, Bossuyt X, Conrad K, Mariette X, Sheldon J, Rönnelid J, Fritzler MJ; members of the committees.

Ann Rheum Dis. 2019 Jun;78(6):e46. doi: 10.1136/annrheumdis-2018-213440. Epub 2018 Apr 17. No abstract available.

PMID:
29666046
26.

Prevalence of Myositis-Specific Antibodies in Idiopathic Interstitial Pneumonias.

De Sadeleer LJ, De Langhe E, Bodart N, Vigneron A, Bossuyt X, Wuyts WA.

Lung. 2018 Jun;196(3):329-333. doi: 10.1007/s00408-018-0108-8. Epub 2018 Mar 12.

PMID:
29532165
27.

Solid phase assays versus automated indirect immunofluorescence for detection of antinuclear antibodies.

Claessens J, Belmondo T, De Langhe E, Westhovens R, Poesen K, Hüe S, Blockmans D, Mahler M, Fritzler MJ, Bossuyt X.

Autoimmun Rev. 2018 Jun;17(6):533-540. doi: 10.1016/j.autrev.2018.03.002. Epub 2018 Mar 8. Review.

PMID:
29526634
28.

Analytical performance of an automated volumetric flow cytometer for quantitation of T, B and natural killer lymphocytes.

Degandt S, Peeters B, Jughmans S, Boeckx N, Bossuyt X.

Clin Chem Lab Med. 2018 Jul 26;56(8):1277-1288. doi: 10.1515/cclm-2017-0638.

PMID:
29466232
29.

Identification of SP1683 as a pneumococcal protein that is protective against nasopharyngeal colonization.

Moens L, Hermand P, Wellens T, Wuyts G, Derua R, Waelkens E, Ysebaert C, Godfroid F, Bossuyt X.

Hum Vaccin Immunother. 2018 May 4;14(5):1234-1242. doi: 10.1080/21645515.2018.1430541. Epub 2018 Feb 21.

30.

Detection of myositis-specific antibodies.

Vulsteke JB, De Langhe E, Claeys KG, Dillaerts D, Poesen K, Lenaerts J, Westhovens R, Van Damme P, Blockmans D, De Haes P, Bossuyt X.

Ann Rheum Dis. 2019 Jan;78(1):e7. doi: 10.1136/annrheumdis-2017-212915. Epub 2018 Jan 25. No abstract available.

PMID:
29371203
31.

Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR/EULAR classification of rheumatoid arthritis.

Van Hoovels L, Jacobs J, Vander Cruyssen B, Van den Bremt S, Verschueren P, Bossuyt X.

Ann Rheum Dis. 2018 May;77(5):667-677. doi: 10.1136/annrheumdis-2017-212365. Epub 2018 Jan 23.

PMID:
29363510
32.

Screening for connective tissue disease-associated antibodies by automated immunoassay.

Willems P, De Langhe E, Claessens J, Westhovens R, Van Hoeyveld E, Poesen K, Vanderschueren S, Blockmans D, Bossuyt X.

Clin Chem Lab Med. 2018 May 24;56(6):909-918. doi: 10.1515/cclm-2017-0905.

PMID:
29306915
33.

Conventional and Single-Molecule Targeted Sequencing Method for Specific Variant Detection in IKBKG while Bypassing the IKBKGP1 Pseudogene.

Frans G, Meert W, Van der Werff Ten Bosch J, Meyts I, Bossuyt X, Vermeesch JR, Hestand MS.

J Mol Diagn. 2018 Mar;20(2):195-202. doi: 10.1016/j.jmoldx.2017.10.005. Epub 2017 Dec 18.

PMID:
29269280
34.

Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used.

Bossuyt X, Delforge M, Reynders M, Dillaerts D, Sprangers B, Fostier K, Poesen K, Vercammen M.

Leukemia. 2017 Nov 20. doi: 10.1038/leu.2017.335. [Epub ahead of print]

PMID:
29151583
35.

Functional Evaluation of an IKBKG Variant Suspected to Cause Immunodeficiency Without Ectodermal Dysplasia.

Frans G, van der Werff Ten Bosch J, Moens L, Gijsbers R, Changi-Ashtiani M, Rokni-Zadeh H, Shahrooei M, Wuyts G, Meyts I, Bossuyt X.

J Clin Immunol. 2017 Nov;37(8):801-810. doi: 10.1007/s10875-017-0448-9. Epub 2017 Oct 10.

PMID:
28993958
36.

Hematopoietic Stem Cell Transplantation in ADA2 Deficiency: Early Restoration of ADA2 Enzyme Activity and Disease Relapse upon Drop of Donor Chimerism.

Bucciol G, Delafontaine S, Segers H, Bossuyt X, Hershfield MS, Moens L, Meyts I.

J Clin Immunol. 2017 Nov;37(8):746-750. doi: 10.1007/s10875-017-0449-8. Epub 2017 Oct 10. No abstract available.

PMID:
28993957
37.

Prognostic value of cryoglobulins, protein electrophoresis, and serum immunoglobulins for lymphoma development in patients with Sjögren's syndrome. A retrospective cohort study.

Kimman J, Bossuyt X, Blockmans D.

Acta Clin Belg. 2018 Jun;73(3):169-181. doi: 10.1080/17843286.2017.1373966. Epub 2017 Oct 3.

PMID:
28971741
38.

Sensitization to Aspergillus fumigatus as a risk factor for bronchiectasis in COPD.

Everaerts S, Lagrou K, Dubbeldam A, Lorent N, Vermeersch K, Van Hoeyveld E, Bossuyt X, Dupont LJ, Vanaudenaerde BM, Janssens W.

Int J Chron Obstruct Pulmon Dis. 2017 Aug 31;12:2629-2638. doi: 10.2147/COPD.S141695. eCollection 2017.

39.

Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis.

Bossuyt X, Cohen Tervaert JW, Arimura Y, Blockmans D, Flores-Suárez LF, Guillevin L, Hellmich B, Jayne D, Jennette JC, Kallenberg CGM, Moiseev S, Novikov P, Radice A, Savige JA, Sinico RA, Specks U, van Paassen P, Zhao MH, Rasmussen N, Damoiseaux J, Csernok E.

Nat Rev Rheumatol. 2017 Nov;13(11):683-692. doi: 10.1038/nrrheum.2017.140. Epub 2017 Sep 14. Review.

PMID:
28905856
40.

Do not forget about pre-analytics in faecal calprotectin measurement!

Oyaert M, Van den Bremt S, Boel A, Bossuyt X, Van Hoovels L.

Clin Chim Acta. 2017 Oct;473:124-126. doi: 10.1016/j.cca.2017.08.025. Epub 2017 Aug 25. No abstract available.

PMID:
28847684
41.

Individual values of antineutrophil cytoplasmic antibodies do not correspond between antigen-specific assays.

Rasmussen N, Damoiseaux J, Csernok E, Heegaard NHH, Hellmich B, Paassen PV, Baslund B, Vermeersch P, Blockmans D, Tervaert JC, Bossuyt X.

Clin Chem Lab Med. 2018 Jan 26;56(2):e39-e42. doi: 10.1515/cclm-2017-0362. No abstract available.

PMID:
28755530
42.

PR3-anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis.

Mahler M, Damoiseaux J, Ballet V, Dillaerts D, Bentow C, Cohen Tervaert JW, Blockmans D, Boeckxstaens G, Aguilera-Lizarraga J, Csernok E, Vermeire S, Bossuyt X.

Clin Chem Lab Med. 2017 Nov 27;56(1):e27-e30. doi: 10.1515/cclm-2017-0346. No abstract available.

PMID:
28755529
43.

A multicentre study to improve clinical interpretation of proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibodies.

Bossuyt X, Rasmussen N, van Paassen P, Hellmich B, Baslund B, Vermeersch P, Blockmans D, Cohen Tervaert JW, Csernok E, Damoiseaux J.

Rheumatology (Oxford). 2017 Sep 1;56(9):1633. doi: 10.1093/rheumatology/kex266. No abstract available.

PMID:
28641391
44.

Fifth Percentile Cutoff Values for Antipneumococcal Polysaccharide and Anti-Salmonella typhi Vi IgG Describe a Normal Polysaccharide Response.

Schaballie H, Bosch B, Schrijvers R, Proesmans M, De Boeck K, Boon MN, Vermeulen F, Lorent N, Dillaerts D, Frans G, Moens L, Derdelinckx I, Peetermans W, Kantsø B, Jørgensen CS, Emonds MP, Bossuyt X, Meyts I.

Front Immunol. 2017 May 12;8:546. doi: 10.3389/fimmu.2017.00546. eCollection 2017.

45.

A multicentre study to improve clinical interpretation of proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibodies.

Bossuyt X, Rasmussen N, van Paassen P, Hellmich B, Baslund B, Vermeersch P, Blockmans D, Cohen Tervaert JW, Csernok E, Damoiseaux J.

Rheumatology (Oxford). 2017 Sep 1;56(9):1533-1541. doi: 10.1093/rheumatology/kex170. Erratum in: Rheumatology (Oxford). 2017 Sep 1;56(9):1633.

PMID:
28541581
46.

Clinical characteristics of patients with low functional IL-6 production upon TLR/IL-1R stimulation.

Frans G, Van der Werff Ten Bosch J, Moens L, Wuyts G, Schaballie H, Tuerlinckx D, De Bie M, Vermeulen F, Schrijvers R, Meert W, Hestand MS, Delanghe J, Vermeesch JR Ir, Meyts I, Bossuyt X.

J Allergy Clin Immunol. 2018 Feb;141(2):768-770. doi: 10.1016/j.jaci.2017.04.017. Epub 2017 May 5. No abstract available.

PMID:
28479328
47.

Evaluation of Autoantibodies in Patients with Primary and Secondary Sjogren's Syndrome.

De Langhe E, Bossuyt X, Shen L, Malyavantham K, Ambrus JL, Suresh L.

Open Rheumatol J. 2017 Jan 31;11:10-15. doi: 10.2174/1874312901711010010. eCollection 2017.

48.

Different Immunological Pathways Underlie the Immune Response to Pneumococcal Polysaccharides.

Moens L, Picard C, Shahrooei M, Wuyts G, Liston A, Fischer A, Bossuyt X.

J Clin Immunol. 2017 Apr;37(3):277-278. doi: 10.1007/s10875-017-0380-z. Epub 2017 Mar 16. No abstract available.

PMID:
28303442
49.

Antineutrophil cytoplasmic antibodies: reporting and diagnostic strategies.

Damoiseaux J, Csernok E, Rasmussen N, Cohen Tervaert JW, Bossuyt X.

Ann Rheum Dis. 2017 Oct;76(10):e39. doi: 10.1136/annrheumdis-2017-211171. Epub 2017 Mar 8. No abstract available.

PMID:
28274911
50.

Negative commercial screening test for paraneoplastic antibodies in a case of opsoclonus.

Vandenbussche N, Cassiman C, Schrooten M, Gille B, Bossuyt X, Vincent T, Van Damme P, Poesen K.

Neurol Neuroimmunol Neuroinflamm. 2017 Feb 3;4(2):e329. doi: 10.1212/NXI.0000000000000329. eCollection 2017 Mar. No abstract available.

Supplemental Content

Loading ...
Support Center